Quick Links

 George Somlo, M.D., F.A.C.P.

  • Professor, Medical Oncology & Therapeutics Research
  • Staff Physician, Hematology & Hematopoietic Cell Transplantation

Professional Experience

2012 - present, Professor, Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA

2004 - 2012, Director, Breast Oncology and Director, High Dose Therapeutics; Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA

2004 - 2012, Co-director, Breast Cancer Program, City of Hope, Duarte, CA

2003 - present, Director, Multiple Myeloma Program, Staff Physician, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

1998 - present, Member, Breast Cancer Guideline Panel, National Comprehensive Cancer Network

Education and Training

1985 - 1988, City of Hope, Duarte, CA. Fellow, Medical Oncology, Department of Medical Oncology & Therapeutics Research and Department of Hematology & Hematopoietic Cell Transplantation.

1982 - 1985, University of California, Irvine and Long Beach, VAMC, Internship and Residency in Internal Medicine.

1972 - 1978, University of Semmelweis Medical School, Budapest, Hungary


This is an abbreviated document. Full CV available upon request. Information on this page may be self-reported. Last updated: 05/12

George Somlo, M.D., F.A.C.P.

 Learn More

My Clinical Trials
My Selected Publications

My Clinical Expertise and Interests:

  • Translational research in breast cancer: Prognostic and predictive indicators of outcome and response to therapy based on the biology of primary tumors.
  • Developmental therapeutics: Target indentification; phase I-II drug development with emphasis on incorporating novel agents into the treatment of breast cancer, sarcomas, and other solid tumors.
  • Multiple Myeloma: The role of autologous and allogeneic stem cell transplantation; identification of targets, incorporation of novel therapeutic agents into the treatment fo myeloma.
  • Stem cell biology: Emphasis on incorporating new cytokines as mobilizing and protective agents of hematopoietic stem cells; redefining the role of dose-intense chemo/radiotherapy and stem cell transplantation for breast cancer; target imaging by utilizing radiolabeled antibodies.

 Search

Go!
Advanced Search Options
News & Publications Search

 Contact Information

To request expert commentary on Breast Cancer, Mammography, or Medical Oncology, contact Media Relations.

To schedule an appointment, call 800-826-HOPE (4673) or complete our online form.